Morphotek, Inc. · Exton, PA United States
Company Description
View Morphotek, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Morphotek has mighty morphin' power, but don't expect to find its products on the shelves of the local toy store. The biotechnology company's morphogenics technology can be used to introduce mutations into DNA that can be developed for drugs, agriculture, and other life sciences or industrial applications. Its MORPHODOMA technology has been licensed by such companies as GlaxoSmithKline , which aims to produce more antibody therapeutics. Morphotek itself is researching and developing antibody therapies for cancer, inflammation, and infectious diseases. Eisai acquired Morphotek in 2007 to bolster its oncological pipeline. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Morphotek, Inc. Financials
| Company Type | Subsidiary Single Location |
| Fiscal Year-End | March |
| Employees | 104 |
Morphotek, Inc. Executives
5 executives listed for Morphotek, Inc.'s Exton, PA location.
| Title | Name & Bio | Contact |
| President, CEO, and Director | Nicholas Nicolaides | Network |
| EVP and COO | Philip Sass | Network |
| VP Project Management and CFO | Rodney Dausch | Network |
Competition
Competitive Landscape for Morphotek, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Morphotek, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!